PROSPECTIVE STUDY OF TREATMENT PATTERN, EFFECTIVENESS, AND SAFETY OF ZOLEDRONIC ACID (ZOL) THERAPY BEYOND 24 MONTHS IN PATIENTS (PTS) WITH MULTIPLE MYELOMA (MM) OR SOLID TUMOR BONE METASTASIS (STM)